Reaction

Diverticulum Intestinal Haemorrhagic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,236 reports · 44 co-occurring drugs

As of the last recalculation, Diverticulum Intestinal Haemorrhagic appears in 2,236 FAERS reports alongside 44 co-occurring drug terms. The strongest observed disproportionality signal is RIVAROXABAN (PRR 85.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Rivaroxaban	1,033	85.0	85.4
Prasugrel Hydrochloride	21	19.4	19.5
Dronedarone	18	16.5	16.6
Clopidogrel	249	13.0	13.1
Febuxostat Tablets 40 Mg	14	12.9	12.9
Febuxostat Tablets 80 Mg	14	12.9	12.9
Dabigatran Etexilate Mesylate	91	12.1	12.1
Dabigatran Etexilate	94	11.7	11.7
Clopidogrel Bisulfate	118	11.3	11.3
Apixaban	76	10.9	10.9
Tamsulosin Hydrochloride	23	10.6	10.6
Aspirin	489	10.6	10.6
Pitavastatin Calcium	11	10.1	10.1
Sotalol Hydrochloride	17	9.6	9.6
Candesartan	35	9.3	9.3
Aspirin 325 Mg	423	9.3	9.3
Aspirin 81 Mg	423	9.3	9.3
Theophylline	11	8.9	9.0
Baricitinib	9	8.7	8.7
Metolazone	10	8.3	8.3
Theophylline Anhydrous	11	8.3	8.3
Febuxostat	14	7.8	7.8
Telmisartan	14	7.3	7.3
Dofetilide	8	7.1	7.1
Amlodipine Besylate And Benazepril Hydrochloride	7	7.1	7.1
Digoxin	53	7.0	7.0
Methoxy Polyethylene Glycol-Epoetin Beta	8	6.8	6.8
Terazosin Hydrochloride	6	6.3	6.3
Heparin Sodium	9	6.1	6.1
Bumetanide	17	6.0	6.0
Ticagrelor	20	5.9	5.9
Isosorbide Mononitrate	13	5.9	5.9
Carvedilol	82	5.8	5.8
Dutasteride	5	5.7	5.7
Warfarin	76	5.7	5.7
Nintedanib	19	5.7	5.7
Iron Sucrose	5	4.9	4.9
Emicizumab	5	3.8	3.8
Tolvaptan	5	3.2	3.2
Sarilumab	9	3.2	3.2
Suvorexant	4	2.9	2.9
Axitinib	6	2.9	2.9
Lenvatinib	10	2.8	2.8
Apalutamide	3	2.4	2.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.